• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.23% Nasdaq Down 0.63%

    Repros Therapeutics Inc. (RPRX)

    -NasdaqCM
    8.22 Down 0.21(2.49%) Apr 27, 4:00PM EDT
    Add to Portfolio
    Prev Close:8.43
    Open:8.54
    Bid:N/A
    Ask:8.49 x 300
    1y Target Est:28.20
    Beta:-0.86
    Earnings Date:May 11 - May 15 (Est.)
    Day's Range:8.14 - 8.60
    52wk Range:5.92 - 22.55
    Volume:304,490
    Avg Vol (3m):335,171
    Market Cap:199.75M
    P/E (ttm):N/A
    EPS (ttm):-1.39
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    RPRXDown 2.49%199.75M
    ABTDown 1.72%71.66B
    ACTDown 3.46%115.50B
    AUXL 0.00%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.17
    Quarterly EPS Est (Mar-15) :-0.31
    Mean Recommendation*:1.6
    PEG Ratio (5 yr expected):0.33

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Repros Therapeutics Inc., a biopharmaceutical company, focuses on the development of new drugs to treat hormonal and reproductive system disorders for male and female in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback